Skip to main content
. 2011 Jan 18;22(6):1420–1426. doi: 10.1093/annonc/mdq613

Table 3.

Distribution of 5922 cases of pancreatic cancer and 11 062 controlsa, OR and corresponding 95% CI according to smoking of different tobacco products and their combinations

Cases, n (%) Controls, n (%) ORb (95% CI)
Never tobacco users 2131 (36.0) 4599 (41.6) 1
Cigarette-only smokers 3075 (51.9) 5149 (46.6) 1.50 (1.39–1.62)
Cigar-only smokers 64 (1.1) 112 (1.0) 1.62 (1.15–2.29)
    Grams of tobacco/dayc
        Never tobacco smokers 1255 (96.5) 3570 (97.4) 1
        <10 22 (1.7) 64 (1.7) 1.20 (0.71–2.01)
        ≥10 16 (1.2) 27 (0.7) 1.82 (0.93–3.55)
        Missing 8 (0.6) 6 (0.2)
        χ2 trend; P-value 3.29; 0.07
    Duration (years)d
        Never tobacco smokers 1477 (96.6) 3768 (97.3) 1
        <20 25 (1.6) 46 (1.2) 1.39 (0.82–2.37)
        ≥20 26 (1.7) 57 (1.5) 1.39 (0.83–2.32)
        Missing 1 (0.1)
        χ2 trend; P-value 2.66; 0.10
Pipe-only smokers 38 (0.6) 99 (0.9) 1.06 (0.69–1.63)
    Grams of tobacco/dayc
        Never tobacco smokers 1255 (98.3) 3570 (97.8) 1
        <10 11 (0.9) 41 (1.1) 0.92 (0.46–1.86)
        ≥10 11 (0.9) 40 (1.1) 0.78 (0.38–1.61)
        Missing 1 (0.0)
        χ2 trend; P-value 0.48; 0.49
    Duration (years)d
        Never tobacco smokers 1477 (98.1) 3768 (97.8) 1
        <20 12 (0.8) 42 (1.1) 0.73 (0.37–1.46)
        ≥20 15 (1.0) 41 (1.1) 1.16 (0.61–2.20)
        Missing 2 (0.1) 2 (0.1)
        χ2 trend; P-value 0.00; 0.98
Cigarette and cigar and pipe 178 (3.0) 276 (2.5) 1.71 (1.36–2.13)
Cigarette and cigar 183 (3.1) 339 (3.1) 1.32 (1.07–1.63)
Cigarette and pipe 206 (3.5) 390 (3.5) 1.43 (1.16–1.75)
Cigar and pipe 47 (0.8) 98 (0.9) 1.13 (0.76–1.69)
    Grams of tobacco/dayc
        Never tobacco smokers 1255 (98.2) 3570 (97.7) 1
        <20 10 (0.8) 53 (1.5) 0.64 (0.31–1.31)
        ≥20 13 (1.0) 29 (0.8) 1.42 (0.70–2.85)
        Missing 2 (0.1)
        χ2 trend; P-value 0.07; 0.80
a

Smokeless tobacco users were excluded (130 cases and 267 controls).

b

Estimates from multiple logistic regression models, adjusted for center, race, sex, age, education, history of diabetes, body mass index and total alcohol consumption.

c

No information was available in the LSU (unpublished data), Toronto [19], Mayo Clinic [18] and MSKCC [17] studies.

d

No information was available in the Mayo Clinic [18] and MSKCC [17] studies.

CI, confidence interval; MSKCC, Memorial Sloan-Kettering Cancer Center; OR, odds ratios.